CVE-2026-21974

CVSS 5.3 MEDIUMEPSS 0.2%CWE-200

Vexday Risk Score

13Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS 5.3EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch referenciado

Lifecycle

20 Jan 2026Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Affected products

Oracle Corporation · Oracle Life Sciences Central Designer

References

https://www.oracle.com/security-alerts/cpujan2026.html